drugset / Trial / NCT03664895
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
RandomizedParallel-groupOpen-labelTreatment
Summary
DELFINO tial is designed to investigate the role of "OFS add on to TMX ", based on MMG density as a surrogate marker in premenopausal women * Premise - MMG density as a surrogate marker of hormone therapy * Assumption - "Add on OFS to TMX" would have further decrease of density * 3-arm(Observation arm + Randomised 2-arm), phase III, RCT with 1:1 allocation
Timeline
- Start
- 2018-09-03
- Primary completion
- 2024-12-02
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Goserelin | Other / unclassified | — | — |
| Comparator | Leuprolide | Other / unclassified | — | — |